Women's Health Alert; Breast Implants and squamous cell carcinoma (SCC

On March 8, the U.S. Food and Drug Administration (FDA) updated the public and healthcare providers, on the information about squamous cell carcinoma (SCC) in the capsule around breast implants. The FDA is aware of nineteen cases of SCC in the capsule around the breast implant from published literature.

The FDA continues to think that occurrences of SCC in the capsule around the breast implant may be infrequent, healthcare providers and individuals who have or are contemplating breast implants should be mindful that cases have been reported to the FDA and in the literature. The FDA continues to request healthcare providers and people with breast implants to report cases of SCC or any other cancers around breast implants to the FDA.

This safety communication update provides:

• Recommendations for people who have or are considering breast implants.
• Recommendations for health care providers.
• FDA actions.
• Instructions for reporting problems related to breast implants.

Learn more: UPDATE: Reports of Squamous Cell Carcinoma (SCC) in the Capsule Around Breast Implants - FDA Safety Communication | FDA

This notice was updated by Anita Johnson-Brown

More News from Los Angeles

• News Mix Top News
• Anita Brown's commentary Opinions matter